Medical Marijuana Inc.

Here is a Look at What 2017 Might Hold for the Company

2016 yielded remarkable growth for Medical Marijuana, Inc. (MJNA) and HempMeds Mexico, a subsidiary company. On Oct. 4, 2016, Hemp Meds announced plans to hold a symposium to provide information on cannabidiol products and derivatives to medical professionals. The symposium, which was held on Oct. 8, was attended by over 100 physicians and focused on the potential benefits of HempMeds Mexico’s products in the treatment of various neurodegenerative conditions. The First National Symposium on Medical Cannabis featured experts such as Dr. Saul Garza, a pediatric neurologist who lives and works in Mexico and Dr. Carols Aguiree who will have an informational study published in Neurology Research International. The study shows twice the efficacy in seizure reduction as per GW Pharma’s Epidiolex – with ZERO adverse side effects. By contrast, 79% of GWs children suffered adverse effects and 30% suffered severe adverse events.

HempMeds Mexico produces zero-Tetrahydrocannabidiol Real Scientific Hemp Oil™, the first cannabis-based treatment to receive import approval from the Mexican federal agency COFEPRIS, which is Mexico’s FDA. This product provides relief for a variety of chronic conditions without the high associated with products that contain THC, making it a viable treatment option for younger patients. The THC-free product was rigorously tested by COFEPRIS for THC content, but none was found. It is the first cannabis-based treatment in the world to be determined safe by World Anti-Doping standards. Even Olympic athletes can use this relief-providing product without going against drug testing regulations. Medical Marijuana, Inc. is already the first publicly traded cannabis company in the United States, and 2017 holds the potential for significant growth for its subsidiary in Mexico as well. Recent import approvals in Latin America make it possible for patients in these areas to receive the life-changing benefits of Real Scientific Hemp Oil™ products.

The 2016 Elections

Recreational marijuana was legalized in California, Nevada, Massachusetts and Maine, opening the door for cannabis companies to reach many new consumers. In addition to these relaxed recreational use restrictions, states such as Arkansas, Florida and North Dakota have also allowed for more comprehensive use of medical marijuana in the treatment of a variety of health conditions. In states where marijuana has been approved for recreational use, it will be regulated and taxed like alcohol. If all existing campaigns are successful, there will soon be 28 states that allow the use of medical marijuana. The results of the American elections could have a worldwide impact since the United States often sets the tone for international regulations. A 2016 Gallup poll shows that an unprecedented 60 percent of Americans now approve of the legalization of cannabis, and it is likely that number will continue to grow. These changes are expected to yield rapid growth for the cannabis industry, and RSHO is poised to meet the increased demand that comes with approval.

RSHO Accomplishments

In 2016, Medical Marijuana’s RSHO™ experienced worldwide market growth with promising new research trials that demonstrated its effectiveness. In one study, 16 percent of children who were given Real Scientific Hemp Oil products as a treatment for refractory epilepsy experienced complete recovery from seizures. Another 60 percent noticed a significant reduction in seizures, demonstrating the efficacy of this treatment. 2016 was also the first year of the ExpoWeed Conference in Mexico. This was the first cannabis conference to be held in Mexico, and it featured industry experts who spoke on the benefits of cannabis-based products used in the treatment of epilepsy and other chronic conditions. This year also saw an increase in physicians using cannabis products to combat the worldwide opioid crisis.

Kannaway, LLC

Kannaway, LLC is a Medical Marijuana, Inc. subsidiary company that offers a lifestyle network marketing approach to the cannabis industry. Kannaway Premium Hemp Oil has recently been added to the Kannaway line of products and it was unveiled at the Kannaway Red Carpet Event in Denver, Colorado. Kannaway Premium Hemp Oil is a cannabinoid blend taken from harvested hemp without any additional ingredients or additives. This blend includes raw and decarboxylated hemp oils and serves as a great source of CBD as well as various vitamins and minerals. Kannaway’s CBD lifestyle products include the Rev!ve nutritional supplement, Rev!ve Pro™, KannaKick, Cannabis Beauty DEFINED and HempVÄP.

Rev!ve is a natural supplement that features 50mg of non-GMO CBD hemp oil in each tube. Rev!ve Pro™ offers an extra-strength formulation of Rev!ve supplements with 1,000mg of CBD hemp oil in each tube. KannaKick is a chewable energy supplement with lower levels of hemp oil and caffeine in a variety of delicious flavors, including sour apple, “icy,” citrus, cinnamon and chocolate. Cannabis Beauty DEFINED is an all-purpose anti-aging skin care product that cleanses, tones, moisturizes and exfoliates with the power of CBD hemp oil. HempVĀP offers the benefits of hemp oil in vaporized cartridge form.

A Promising 2017 for Medical Marijuana, Inc.

2016 was a year of remarkable success for Medical Marijuana, Inc. and its subsidiary companies, and 2017 holds even more in store for the company and its devoted consumers and investors. Real Scientific Hemp Oil and Kannaway products are changing the way consumers look at cannabis-based products and offering practical solutions to real problems. Additionally, the incubation and development of AXIM Biotech, which Medical Marijuana, Inc. owns a 45% ownership stake of, has seen recent share price appreciation as well as expected future results from early stafe, pre-clinical trials. Next year it looks to achieve full stage 3 clinical trials for its product MedChew, plus CanChew Plus and AX-1602 efforts as well. As permissions for medical marijuana continue to expand in Latin America and worldwide, Medical Marijuana, Inc. will be able to reach consumers in a broader, global market.

About the Author

Stuart Smith is the CEO and Founder of is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit